The creation of efficient and effective healthcare systems to ensure innovation and sustainability is a common issue not only in Japan, but in every country worldwide. Efforts are being made country by country to appropriately assess medical treatments. For example, some people expect that cost-effective healthcare and optimal allocation of resources may become possible via Health Technology Assessment (HTA). In Japan, there have been discussions held for the introduction of HTA particularly at the Committee for Cost-Effectiveness Assessment within the Central Social Insurance Medical Council (Chuikyo) since FY2012. The trial introduction of Cost-Effectiveness Assessment was conducted, and the dialogue will be continued in FY2018 towards a full-scale introduction.

 

At this Preparatory Meeting, as a kick-off for the main FY2018 series, we will identify priority tasks to be addressed in the FY2018 forums, based on the results from the HGPI Global Expert Meetings held in FY2017 (April, October), as well as issues highlighted through the trial introduction of Cost-Effectiveness Assessment, and subsequent discussions held at Chuikyo. 

Experts: A roundtable discussion with around 20 domestic and international experts 

18:30-18:40 Opening (explanatory introduction)

18:40-19:30 Opening remarks by roundtable speakers 

19:30-20:30 Discussions on topics/agenda to be covered in the FY2018 forum series

Examples: 

• • ■Values in medical treatments and consistency with other policies, etc.
  • ■Lack of human resources for implementation of cost-effectiveness 
  • assessment (among all stakeholders including industry, academia, government and civil society)
  • ■Communication among stakeholders including companies and re-analysis teams 
  • ■Methods for analyzing medicines and medical devices and their rationales 

20:30 Closing